Trevi Therapeutics, Inc. TRVI Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award options exercises in period total intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Trevi Therapeutics, Inc. (TRVI) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $1.08B in Q4 2025.
- How has Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award options exercises in period total intrinsic value changed year-over-year?
- Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award options exercises in period total intrinsic value increased by 1421867.2% year-over-year, from $76.25K to $1.08B.
- What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
- The total difference between the market price of the company's stock at the time of exercise and the exercise price of the options. This reflects the realized economic gain captured by employees and the potential dilution impact on existing shareholders.